; (C) means any article that contains either marihuana , as defined in section 102(16) of the Controlled Substances Act, that also meets the standards set forth in an official compendium; and (D) does not mean articles or cannabis products produced and intended for nonmedical use, such as those regulated under title III of the Federal Alcohol Administration Act ( 27 U.S.C. 201 et seq. ). (2) The term State includes the District of Columbia, Puerto Rico, and any commonwealth, territory, enclave, Indian Tribe, or possession of the United States. 360ggg–1. Regulation of medical cannabis products (a) Medical cannabis regulation and authority The Food and Drug Administration shall have jurisdiction over the regulation of designated State medical cannabis products described herein. (b) Certification of designated state medical cannabis products (1) Submission Beginning 210 days after the effective date of this Act, any person who seeks to initially introduce or deliver for introduction a designated State medical cannabis product into interstate commerce may file with the Secretary a request for certification as a designated State medical cannabis product. Any such request shall contain the following information: (A) A description of the designated State medical cannabis product. (B) The name and address of the sponsor. (C) The name and address of the facility or facilities where the designated State medical cannabis product is or will be cultivated and manufactured. (D) Any other information deemed appropriate by the Secretary to determine whether the designated State medical cannabis product is in fact a designated State medical cannabis product. (2) Grant of certification The certification requested under paragraph (1) is deemed to be granted unless, within 30 days of the filing of such request, the Secretary finds that— (A) the designated State medical cannabis product subject to the certification is not in fact a designated State medical cannabis product